Drugs / Glycine Buffer
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03617718 | Nov 2018 → Jul 2025 | asthma, cystic fibrosis | Case Western Reserve University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glycine Buffer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03617718 ↗ |
| Route | Inhaled | “The Glycine Buffer Challenge test includes giving an investigational drug to breathe in (inhale).” NCT03617718 ↗ |